↓ Skip to main content

Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Overview of attention for article published in Clinical Drug Investigation, July 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
94 Mendeley
Title
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Published in
Clinical Drug Investigation, July 2019
DOI 10.1007/s40261-019-00826-0
Pubmed ID
Authors

Katherine A. Lyseng-Williamson

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 94 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 16%
Student > Master 12 13%
Researcher 9 10%
Other 8 9%
Student > Ph. D. Student 6 6%
Other 12 13%
Unknown 32 34%
Readers by discipline Count As %
Medicine and Dentistry 30 32%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Nursing and Health Professions 9 10%
Biochemistry, Genetics and Molecular Biology 5 5%
Computer Science 2 2%
Other 7 7%
Unknown 31 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2019.
All research outputs
#13,073,150
of 23,152,542 outputs
Outputs from Clinical Drug Investigation
#641
of 982 outputs
Outputs of similar age
#159,730
of 347,197 outputs
Outputs of similar age from Clinical Drug Investigation
#7
of 14 outputs
Altmetric has tracked 23,152,542 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 982 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,197 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.